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Abstract
Background
Schistosomiasis (or bilharzia), a major parasitic disease, affects more than 260 million peo-
ple worldwide. In chronic cases of intestinal schistosomiasis caused by trematodes of the
Schistosoma genus, hepatic fibrosis develops as a host immune response to the helminth
eggs, followed by potentially lethal portal hypertension. In this study, we characterized
hepatic and splenic features of a murine model of intestinal schistosomiasis using in vivo
magnetic resonance imaging (MRI) and evaluated the transverse relaxation time T2 as a
non-invasive imaging biomarker for monitoring hepatic fibrogenesis.
Methodology/Principal Findings
CBA/J mice were imaged at 11.75T two, six and ten weeks after percutaneous infection
with Schistosoma mansoni. In vivo imaging studies were completed with histology at the
last two time points. Anatomical MRI allowed detection of typical manifestations of the intes-
tinal disease such as significant hepato- and splenomegaly, and dilation of the portal vein
as early as six weeks, with further aggravation at 10 weeks after infection. Liver multifocal
lesions observed by MRI in infected animals at 10 weeks post infection corresponded to
granulomatous inflammation and intergranulomatous fibrosis with METAVIR scores up to
A2F2. While most healthy hepatic tissue showed T2 values below 14 ms, these lesions
were characterized by a T2 greater than 16 ms. The area fraction of increased T2 correlated
(rS = 0.83) with the area fraction of Sirius Red stained collagen in histological sections. A
continuous liver T2* decrease was also measured while brown pigments in macrophages
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were detected at histology. These findings suggest accumulation of hematin in infected
livers.
Conclusions/Significance
Our multiparametric MRI approach confirms that this murine model replicates hepatic and
splenic manifestations of human intestinal schistosomiasis. Quantitative T2 mapping proved
sensitive to assess liver fibrogenesis non-invasively and may therefore constitute an objec-
tive imaging biomarker for treatment monitoring in diseases involving hepatic fibrosis.
Author Summary
Schistosomiasis (or bilharzia), a major helminth disease, affects more than 260 million
people worldwide. While the adult worms survive for years within veins of the gastrointes-
tinal system, symptoms are due to inflammatory reactions to their eggs in several organs.
Hepatic fibrosis may develop in chronic cases of infection with Schistosoma mansoni and
lead to portal hypertension with potentially lethal complications. In this study, we aimed
at establishing a non-invasive quantitative and readily available magnetic resonance imag-
ing (MRI) technique to monitor in vivo the development of hepatic fibrosis and portal
hypertension in Schistosoma mansoni infected mice. We evaluated the transverse relaxa-
tion time T2, an easily measurable MRI parameter, as an early and quantitative imaging
biomarker for hepatic fibrogenesis and validated it with histological techniques for fibrosis
detection and quantification. In addition, we confirmed that this mouse model of schisto-
somiasis replicates the human pathology closely. The quantitative imaging biomarkers val-
idated in this study will aid in the preclinical and clinical evaluation of new therapeutic
strategies against hepatic fibrogenesis.
Introduction
Present in many tropical and subtropical countries, schistosomiasis (or bilharzia), the second
most prevalent parasitic disease in the world after malaria, affects more than 260 million people
and leads to 200 000 deaths per year [1]. This helminthic disease is caused by trematodes of the
Schistosoma genus. S. haematobium, S.mansoni, and S. japonicum are the main species infect-
ing humans. These parasites have aquatic gastropods as intermediate hosts and a final verte-
brate host. S.mansoni is the principal agent of digestive forms of the human disease. The
gastropod is infected withmiracidia released from the S.mansoni eggs that transform into spo-
rocysts. These sporocysts shed cercariae in the water that can penetrate the skin of the mamma-
lian hosts. After maturation, male and female worms reproduce in the mesenteric venous
plexus and produce eggs that are discharged with the stool into the environment [2,3,4].
However, many eggs are not eliminated and disseminate in the intestines and the liver
where they obstruct presinusoidal capillary venules [2,4,5]. The host immune response elicited
by these eggs leads to the formation of periovular granulomas and tissue damage. An imbal-
ance between scarring and regeneration causes an accumulation of extracellular matrix rich in
collagen (particularly types I and III) leading to hepatic fibrosis [6]. Hepatomegaly occurs early
in the disease as a consequence of the granulomatous inflammation [2,3]. In ca 10% of patients,
5–20 years after infection, serious complications occur such as splenomegaly, pulmonary arte-
rial hypertension accompanied by right heart failure, periportal fibrosis resulting in portal
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hypertension and esophageal varices, that can lead to ascites and gastrointestinal bleeding with
high mortality [3,4,5,7,8]. Chronic schistosomiasis is also associated with an increased inci-
dence of hepatocellular carcinoma [4,9]. The standard treatment is the trematodicide Prazi-
quantel, which kills adult worms, but is ineffective on juvenile mammalian-stage schistosomes.
The mechanism of action and molecular targets of Praziquantel are unknown. However many
studies have reported vacuolation and blebbing of worm teguments and suggested a direct dis-
ruptive effect on Ca2+ channels, whereas a recent work has described distinct effects on male
and female worms [10,11]. Although effective even at a single dose, reinfection is frequent and
in 2013 only 13% of people necessitating treatment could benefit from it [1]. Despite extensive
research, an anti-schistosomiasis vaccine is not yet available [12,13].
The mouse model of schistosomiasis is well suited for pharmaceutical and basic research
purposes since mice are infected with the parasite species that are pathogenic for humans, and
are therefore expected to accurately recapitulate the pathological features of the human disease.
The objective of this study was to provide the first characterization of hepatic and splenic fea-
tures of murine intestinal schistosomiasis using in vivomagnetic resonance imaging (MRI).
Another aim was to search for non-invasive biomarkers allowing future evaluation of new ther-
apeutic strategies against the intestinal form of the disease in murine models.
Ultrasound is the leading medical imaging examination for the diagnosis of human intesti-
nal schistosomiasis, and allows the assessment of liver involvement and portal hypertension
[14,15]. Liver fibrosis can be monitored using ultrasound transient elastography (FibroScan), a
technique allowing the assessment of liver stiffness [16]. Elastography is based on the measure-
ment of tissue elasticity following the propagation of a mechanical shear wave through the
liver. However, ultrasound transient elastography has the disadvantage of being highly opera-
tor dependent, less reliable for deep organs and not readily available for the exploration of
rodent models [17]. Analysis of texture features from computed tomography (CT) images
enables staging of fibrosis throughout the liver, but is less accurate in case of heterogeneous
fibrosis distribution and is considered inferior to ultrasound transient elastography [18].
Whole abdominal coverage can also be achieved with MRI. In addition to the detection of mor-
phological indicators of liver fibrosis such as splenomegaly and portal hypertension on conven-
tional images [19], various MRI methods can be used for the study of (schistosomiasis-
induced) liver disease. Magnetic resonance elastography (MRE) measures viscoelastic proper-
ties of the liver tissue, namely its capacity to return with time to its original shape after the
application of deforming forces, by quantifying the propagation of the shear waves. This tech-
nique can be implemented on standard MRI systems but requires a mechanical vibrator device
for the generation of shear waves. Liver stiffness has been shown to correlate with fibrosis stage
in patients [20] and animal models [21]. A recent study suggests that MRE more accurately dis-
criminates between early fibrosis stages than ultrasound transient elastography [22]. However,
increased liver stiffness is not specific for fibrosis [23], and MRE can be hampered in subjects
with severe iron overload [22]. Qualitative and quantitative scores of liver texture features on
double contrast-enhanced MRI, an MRI technique based on the injection of two different types
of contrast agents (super paramagnetic iron oxides and gadolinium chelates) have been shown
to distinguish between mild and severe fibrosis [24]. In rodent models, MRI using a collagen
type I targeted gadolinium-based contrast agent has shown differential uptake and washout in
fibrotic livers with a good correlation to histological quantification of collagen [25,26]. Diffu-
sion-weighted MRI, a technique sensitive to water diffusivity generally used to study tissue
microstructure, has also been performed since fibrosis is expected to restrict water motion [27].
However, due to lack of standardization and confounding factors such as altered perfusion or
accompanying inflammation this technique is not sensitive to mild stages of liver fibrosis
[28,29]. Another MRI technique, known as intravoxel incoherent motion imaging [30] can
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distinguish between microscopic motion of water molecules in intra- and extracellular com-
partments and the microcirculation of blood. Consequently, the derived parameters correlate
better with fibrosis stage than conventional diffusion-weighted imaging in patients [31] and
animal models [32]. However, this technique has not proved superior to MRE in distinguishing
mild to intermediate fibrosis stages in patients [33]. Relaxometry has been proposed for the
staging of hepatic fibrosis and evaluated in a number of studies. Relaxometry studies magnetic
relaxation, a process by which magnetization of magnetic nuclei returns to its equilibrium state
(parallel to the static magnetic field, B0) after it was disturbed from equilibrium and tipped into
the plane orthogonal to B0 (transverse plane) by a radiofrequency pulse. Two relaxation time
constants can be measured: the longitudinal relaxation time-constant T1 corresponding to the
recovery of the magnetization along B0, and the transverse relaxation time-constant T2 describ-
ing the decay of the magnetization in the transverse plane. Another relaxation time, called T2,
is a measure of T2 taking into account the effects of static magnetic field inhomogenities on
relaxation. Relaxation time constants depend on tissue structure and composition, which may
vary with physiological or pathological processes, and strongly influence contrast in MRI.
Maps derived fromMRI images representing a spatial distribution of quantitative values of a
selected relaxation time-constant (T2, T2 or T1) can be generated. Although relaxation time-
constant values may vary with magnetic field strength, the tendency to increase or decrease
upon a physiological or pathological process is independent of the magnetic field strength. An
increase of the longitudinal relaxation time T1 has been observed with increasing severity of
hepatic fibrosis. However, alterations of the transverse relaxation time T2 during the process of
hepatic fibrogenesis were generally more sensitive [34,35,36]. In particular, in pre-clinical MRI
studies using MRI systems equipped with high or ultra high magnetic field strength (3T< B0
< 21T) to increase the spatial resolution or the signal-to-noise ratio, T1 relaxation times tend
to differ less between tissues than transverse relaxation times. In addition, T2 mapping is less
challenging than T1 mapping in conjunction with respiratory gating (synchronization of MRI
sequences with respiration) since all echoes required for T2 analysis are acquired within a few
hundred milliseconds, while T1 mapping requires repeated sampling over a couple of seconds.
The T2 and T2 relaxation times are also sensitive markers of iron deposition and hemorrhage
[37,38].
In this study, multiparametric MRI including quantitative T2 and T2 mapping was per-
formed in an attempt to establish a quantitative measure of the liver damage and related com-
plications caused by schistosomiasis, and in particular to assess early stages of liver fibrosis. A
mouse model of the intestinal form of the disease obtained with S.mansoni was explored. In
vivo anatomical and relaxometry findings were compared to histological staging of liver disease
and fibrosis progression.
Materials and Methods
Ethics statement
Animal studies were in agreement with the French guidelines for animal care from the French
Ministry for Agriculture (Animal Rights Division), the directive 2010/63/EU of the European
Parliament and of the Council of 22 September 2010, and approved by our institutional com-
mittee on Ethics in animal research (Comité d’Ethique de Marseille n°14, project authorization
n°: 02157.02).
Animals and schistosomiasis induction
Twenty-four female CBA/J mice (6-week old) from Charles River Laboratories (l’Arbresle,
France) were used. Mice were maintained at 22.5°C with a 12h light/12h dark cycle in an
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enriched environment with free access to food and water. Twelve mice were infected percuta-
neously at the age of seven weeks with 30 cercariae of the Venezuelan strain of S.mansoni
under intraperitoneal anesthesia (ketamine 100 mg/kg, xylazine 4 mg/kg). Cercariae, which are
maintained in our laboratory by passage through Biomphalaria glabrata snails, were counted
under binocular microscope, diluted in 500 μl of water, and placed for 60 minutes on the
sheared abdomen of mice to replicate the natural route of infection.
Mice were weighed before each MRI session. In vivoMRI was performed on two animal
cohorts. The first cohort included a group of 6 infected mice and a group of 6 uninfected mice,
which were both imaged at 2 weeks and 6 weeks post infection. MRI at 6 weeks was followed
by histology. The second cohort consisting of a group of 6 infected mice and a group of 6 unin-
fected mice was explored only once at 10 weeks post infection and the animals were sacrificed
after MRI for histology.
In vivoMRI protocol
MRI experiments were performed on a Bruker AVANCE 500 WBMR system (Bruker, Ettlin-
gen, Germany) operating at very high magnetic field (11.75 T), equipped with actively shielded
gradients (1 T/m maximum gradient strength and 9 kT/m/s maximum slew rate) and a 30
mm-diameter transmitter/receiver volume birdcage coil. A catheter was inserted into the intra-
peritoneal cavity of the mice for contrast agent delivery. The animals were positioned in a cra-
dle, and a pneumatic pressure probe was placed under their chest for respiration monitoring.
Anesthesia was maintained with isoflurane in air using 1.3–1.8% via a face mask and body tem-
perature was maintained using the water circulation of the gradient cooling system set to 42°C.
All sequences were prospectively gated with respiration using an MRI compatible monitor-
ing and gating system (PC-SAM, Small Animal Instruments Inc., Stony Brook, NY). Images
were acquired in the transverse plane with a field of view of 24×24 mm2 and a slice thickness of
0.5 mm. Structural imaging at high in plane resolution (matrix 240×240, in-plane resolution
100 μm) was performed using a 2D spin-echo sequence (repetition time TR 448 ms; echo
time TE = 14 ms) with 20 contiguous slices and repeated on adjacent 20 slices to cover the liver
and spleen entirely. Images were acquired before and 15 minutes after intraperitoneal injection
of a paramagnetic contrast agent (50 μl of 0.5 M gadoteric acid, DOTAREM, Guerbet, Ville-
pinte, France) (number of accumulations for each acquisition: 2 and 4 respectively). Prior to
contrast agent injection, T2 and T2 maps (TR 9 s; matrix 64×64, 2 accumulations) were
acquired in a single slice positioned 0.5 mm caudal of the bifurcation of the portal vein, using a
multi-spin echo sequence (12 equally spaced echoes at TE = 7.5 to 120 ms) and a multi-gradi-
ent echo sequence (8 equally spaced echoes at TE = 1.6 to 13.5 ms), respectively. Using the
bifurcation of the portal vein as landmark this axial slice position was reproducible between
animals and covered sufficient liver tissue. Respiratory rate was kept between 60 and 70 breaths
per minute by adjusting the isoflurane percentage leading to a total acquisition time of approxi-
mately 15 min for the anatomical imaging and 20 min for each map. For quality control, an
external reference with a known T2 of ca 21 ms, consisting of a capillary filled with the para-
magnetic contrast agent diluted in saline was placed in the image field of view.
MRI relaxometry of collagen solutions
Relaxometry studies were performed at 11.75T on water and solutions of collagen at four dif-
ferent concentrations (1.66 g/L, 3.33 g/L, 6.25 g/L and 12.5 g/L). Collagen solutions were pre-
pared with Type I collagen from rat tail (Sigma-Aldrich, St Quentin Fallavier, France)
solubilized under magnetic stirring in 0.1 M acetic acid at 40°C. T1 and T2 relaxation times
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were measured using an inversion recovery gradient echo sequence with 7 inversion times
(Tinv 15 ms to 15 s) and a multi-spin echo sequence with 80 TE (10 to 800 ms). TR was 20 s.
MRI processing
Images were analyzed under ImageJ (Rasband, W.S., ImageJ, U. S. National Institutes of
Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/, 1997–2014, last access January
2015) for liver and spleen volumetry, portal vein diameter, and T2-map generation.
Liver and spleen were delineated on each slice (i) to measure the cross-section (Ai) of the
organ and estimate its volume in mm3 by V ¼ 0:5
X
i
Ai. To assess portal hypertension, the
portal vein cross-section was measured 0.5 mm caudal of the portal bifurcation, and its diame-
ter was estimated as the Feret’s diameter. The Feret’s diameter is the maximum caliper length
namely the longest distance between any two points along the section boundary. Relaxation
time maps were computed by ﬁtting the signal intensity S to SðTEÞ ¼ S0expðTE=T ðÞ2 Þ or S
(Tinv) = S0|1 − 2E exp(−Tinv/T1)| using the simplex algorithm in ImageJ. Here, S0 is the signal at
thermal equilibrium, and E the efﬁciency of the inversion pulse. Histograms of quantitative T2
and T2 were obtained from a large region of interest (ROI) covering the liver but excluding the
hepatic hilus and large vessels as well as the gall bladder, bowels or stomach when present in
the slice.
Histology
After euthanasia, livers were fixed in 10% buffered formalin for a minimum of 48 hours, sam-
pled according to standardized procedures [39], paraffin-embedded and routinely processed
for histology. Three 3-μm paraffin serial sections per mouse were stained with Hematoxylin-
Eosin (HE), with Sirius Red for collagen, and Perls’ stain for iron. Grading of inflammatory
activity and staging of fibrosis was performed according to the METAVIR scoring system, a
histological scale used to quantify the degree of inflammation and fibrosis of a liver biopsy. “A”
refers to the intensity of necrosis and inflammation and may vary from A0 to A3 (A0 = no
activity, A1 = mild activity, A2 = moderate activity, and A3 = severe activity). “F” refers to the
extent of fibrosis and may vary from F0 to F4 (F0 = no fibrosis, F1 = portal fibrosis without
septa, F2 = portal fibrosis with rare septa, F3 = numerous septa without cirrhosis, and
F4 = cirrhosis) [40]. Sirius Red stained sections were examined by semiautomatic computer-
based morphometry using the NIKON DS-Fi2 camera and NIS Elements imaging software
(Nikon, Japan). Morphometric analysis was made on one entire lobe section, measuring semi-
automatically delineated Sirius Red stained zones (S1A Fig) and subtracting when present the
egg area or unstained central granuloma area deprived of collagen deposition. All analyses
were performed in a blinded manner.
Statistics
Statistical analyses were performed using either GraphPad Prism version 5.00 (San Diego, CA)
or JMP 9.0 (SAS, Cary, NC). Values are reported as means ± standard deviation. The non-
parametric Mann-Whitney test was used to compare uninfected and infected mice at each time
point. The Kruskal-Wallis test was used to compare the METAVIR score or the percentage of
Sirius Red stained zones among controls and diseases mice at 6 and 10 weeks after infection.
Correlations between T2 values and METAVIR score or T2 values and fibrosis quantification
by Sirius Red were performed using the Spearman test. The Smirnov test was used to compare
distributions from two independent samples [41]. Values of P<0.05 were considered
significant.
In VivoMRI of Murine Schistosmiasis
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Results
Clinical follow-up
Weight control performed before each MRI session showed a continuous increase without sig-
nificant difference between infected and control groups at any time point. No signs of general
health alteration, such as cachexia, reduced mobility or behavioral changes were observed, sug-
gesting animals were in good health condition during the study. All the animals of the first
cohort exposed to the cercariae of S.mansoni were successfully infected as confirmed by MRI
and histology at 6 weeks after infection, whereas only 4 out of 6 mice of the second cohort were
successfully infected and developed hepatosplenic signs as shown by MRI and histology at 10
weeks after infection.
In vivoMRI
All the images acquired were of good quality, except one T2 map obtained from a control ani-
mal of the second cohort, which showed motion artefacts and therefore was not included in the
analysis. The two mice of the second cohort in which the infection had failed were also dis-
carded from the analysis.
While no differences were detected between infected and control groups at 2 weeks post
infection by anatomical MRI (Fig 1A) and relaxometry, anatomical MRI was able to detect
signs related to murine schistosomiasis (Fig 1B–1D) as early as 6 weeks post infection. Indeed,
hepatomegaly (Fig 1B), splenomegaly (Fig 1C), and portal hypertension (Fig 1D) as assessed by
MRI were significant at 6 weeks: +19% (P = 0.0043), +52% (P = 0.0087) and +60% (P = 0.0087)
and progressed to +72% (P = 0.0095), +170% (P = 0.0095) and +139% (P = 0.0139) 10 weeks
post infection, respectively. The evolution of the portal vein diameter was similar to that of the
cross-section (control: 1.19±0.12 mm, infected: 1.25±0.13 mm, P = 0.393 at 2 weeks, control:
1.17±0.19 mm, infected: 1.43±0.16 mm, P = 0.027 at 6 weeks, and control: 1.16±0.10 mm,
infected: 1.68±0.13 mm, P = 0.004 at 10 weeks). However, the most remarkable findings were
multifocal hyperintensities (disseminated “white spots”) of the liver in 4 infected mice at 10
weeks post infection (Fig 1A). These hyperintensities were visible before contrast agent injec-
tion (Fig 2A), and were contrast-enhanced after injection.
The average T2 value in hepatic ROIs (Fig 2A) at 10 weeks post infection was not signifi-
cantly increased compared to the average T2 value in control livers (control: 10.4 ± 1.3 ms,
infected: 12.2 ± 1.5 ms, P = 0.1714). However, the distributions of hepatic T2 values in infected
and control mice were different (Fig 2B). The area fraction with 16 ms< T2< 26 ms was
13.4 ± 6.9% in infected animals at 10 weeks, while it was 1.1 ± 1.0% in control mice (Kruskal-
Wallis test P = 0.0048) (Fig 2C). Liver T2 values> 16 ms on the T2 maps were co-localized
with the hyperintensities on anatomical images (Fig 2D). The distributions of T2 values in the
livers of infected mice were shifted to lower values at 6 weeks (average T2 = 5.4 ± 1.5 ms in
infected mice versus T2 = 5.8 ± 1.6 ms in control mice) and at 10 weeks (average T2 =
4.6 ± 1.5 ms in infected mice versus T2 = 6.1 ± 1.5 ms in control mice) post infection (Fig 2E).
Relaxometry of MRI solutions of collagen
Relaxometry studies performed on collagen solutions did not reveal any significant change of
either T1 or T2 relaxation time with increasing collagen concentration (Fig 3).
Histology
Histology showed that adult parasites (Fig 4A) and eggs began to lodge in the liver with mini-
mal inflammation and occasionally with isolated periovular granulomas (S1B Fig) by 6 weeks
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post infection, corresponding to METAVIR scores A1F0. All infected animals showed dis-
crete periportal and portal inflammation at 6 weeks post infection but only one of them was
considered A1F0. The number of eggs trapped in liver tissue dramatically increased thereafter.
By 10 weeks post infection, 4 mice presented with severe portal fibrosis with granulomatous
chronic inflammation, corresponding to METAVIR scores of A1F1 to A2F2 (Fig 4B–4H). Eggs
were surrounded by a dense population of immune cells, with mild to marked extracellular
matrix deposition leading to intergranulomatous fibrosis and fusion of several granulomas
replacing some portal spaces (Fig 4E–4H).
In a large number of advanced stage granulomas, pigment accumulation in macrophages
(S1C Fig), which appeared negative on the Perls’ stain (S1D Fig), was present. This is highly
suggestive of hematin, a degradation product of hemoglobin excreted by the worm [42]. Histol-
ogy confirmed the absence of lesions in the two remaining mice in which the infection had
failed; consequently these mice were excluded from analysis.
METAVIR score and area fraction of fibrosis stained with Sirius Red increased simulta-
neously from 6 weeks post infection on (Fig 5A and 5B) and were both significantly correlated
Fig 1. MRI signs of organomegaly and portal hypertension. (A) Comparison of contrast-enhanced anatomical MRI covering liver and spleen in a
representative infected and a control mouse at 2, 6, and 10 weeks post infection. Two images are shown for each mouse, one centered on the liver and the
portal vein (left image for each couple of images), and another one showing the spleen (right image). A multifocal liver and spleen damage is observable at 10
weeks. Spleen (vertical arrows), portal vein (oblique arrows), liver multifocal hyperintensities (arrowheads). The circular object is the external reference tube.
Progressive increases in hepatic volume (B), spleen volume (C) and portal vein cross section (D) are detected from week 6 to10 after infection. (*P<0.05,
**P<0.01), filled squares = infected animals, empty squares = control animals. Abbreviations: L = liver, PV = portal vein, S = spleen.
doi:10.1371/journal.pntd.0004036.g001
In VivoMRI of Murine Schistosmiasis
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004036 September 22, 2015 8 / 16
with the area fraction of T2 values comprised between 16 and 26 ms (Fig 5C and 5D) at 10
weeks after infection. Since control values obtained at 6 and 10 weeks for the METAVIR score
or the Sirius Red staining were identical (A0F0, or 0% respectively), they were pooled in the sta-
tistical analysis (Fig 5A and 5B). The correlations obtained for the values measured at 6 and 10
weeks are shown in S2A and S2B Fig.
Discussion
To our knowledge, this is the first time a murine model of schistosomiasis is evaluated by quan-
titative MRI. Anatomical MR images of S.mansoni infected mouse liver had already been pub-
lished, but a systematic follow-up during disease development was not reported [43]. These
Fig 2. Quantitative T2 and T2*mapping at 10 weeks post infection. (A) Non contrast-enhanced anatomical acquisitions, T2 and T2*maps for two
representative mice from the control and the schistosomiasis group (color bar range: 0 to 50 ms for T2 maps, 0 to 20 ms for T2*maps). Spatial patterns of
increased T2 and decreased T2* can be observed in the infected mouse. The external reference has an average T2 of 21.55 ± 0.25 ms (2 weeks: 21.74±0.22
ms, 6 weeks 21.64 ± 0.65 ms, 10 weeks: 21.26±0.60 ms, P = 0.1139). Regions of interest (ROI) in the liver used for analysis are shown on the anatomical
acquisitions. (B) At 10 weeks post infection the T2 distribution is enlarged (P < 0.01) in infected (n = 4) compared to control livers (n = 6) with a fraction of
values exceeding 16 ms. (C) The area fraction with T2  [16 ms;26 ms] is significantly increased at 10 weeks post infection compared with control mice
(Dunn’s Multiple Comparison Test P < 0.05). The overlay (D) shows that hepatic regions with increased T2 co-localize with hyperintensities seen in the
anatomical images prior to Gd-DOTA injection. These hyperintense lesions further enhance after Gd-DOTA injection, but organ displacement prevents
pixelwise comparison with T2 maps. (E) Distributions of hepatic T2* values at 10 weeks post infection showing decreased T2* values (P < 0.01) in the
infected mice (n = 4) compared to controls (n = 5).
doi:10.1371/journal.pntd.0004036.g002
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images were obtained from a mouse infected with subcutaneous injection of 150 cercariae,
while our model relies on the percutaneous administration of only 30 cercariae, replicating the
natural route of infection and leading to a similar disease burden obtained with the injection of
150 cercariae. The pathological findings obtained with in vivoMRI in this model are in accor-
dance with known features of the human disease, confirming its relevance to human disease.
Volumetric analyses revealed hepato- and splenomegaly as well as portal vein cross section
increase as early as 6 weeks post infection, and reliably detected aggravation of these signs dur-
ing disease progression. These symptoms are unlikely to be a consequence of hepatic fibrosis,
which was undetectable at 6 weeks post infection, but rather of vascular damage and obstruc-
tion caused by the schistosome eggs [7,44]. Hepatic tissue alteration and iron accumulation
were detected 10 weeks post infection by MRI as T2 and T2 changes, respectively, and were
confirmed by histology.
From a technical point of view, the multiparametric MRI protocol used in this study was
sensitive enough to monitor disease severity and identify infection failure in two out of 6 mice.
In particular, the correlation with the area fraction of collagen stained with Sirius Red in liver
histology shows that the transverse relaxation time T2 can be used as a quantitative non-inva-
sive biomarker of hepatic fibrosis.
Few techniques are sensitive to potentially reversible early stages of liver fibrosis. All existing
imaging approaches rely on the measurement of parameters that are only indirectly related to
liver fibrosis (tissue stiffness, restricted water diffusion). Likewise, relaxation time constants
depend on physicochemical properties that are altered during fibrogenesis. In ex vivo studies,
correlation between transverse relaxation times and fibrosis has been controversial. For exam-
ple, at 11.75T a T2 decrease has been observed in a 3,5-diethoxycarbonyl-1,4-dihydrocollidine
induced mouse model of hepatic fibrosis [45]. But in another study at 0.94T a positive correla-
tion between liver T2 and degree of fibrosis was observed in a thioacetamide induced mouse
model of liver cirrhosis [34]. It is known that the T2 is a rather unspecific parameter, influenced
by inflammation [34,46], edema, perfusion changes or steatosis [47]. Indeed, free water is char-
acterized by a long T2 (hundreds of ms) whereas lipids have much shorter T2 values (tens of
ms). In the vast majority of cases, severe hepatic fibrosis in human schistosomiasis is not
Fig 3. Relaxometry of collagen solutions. This figure shows the absence of significant variation of
relaxation time-constants with collagen concentration.
doi:10.1371/journal.pntd.0004036.g003
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associated with ultrasound detectable steatosis namely the accumulation of triglycerides in
hepatocytes, except in patients with obesity or diabetes. Most subjects with severe disease are
rather underweight. Moreover, liver metabolic profiling by 1H nuclear magnetic resonance
spectroscopy revealed reduced levels of lipids in S.mansoni infected mice [48]. In agreement
with previous results [49], our in vitro experiments show that collagen at concentrations up to
12.5 g/L does not significantly modify the relaxation times. The range of collagen concentra-
tions tested in our phantom studies corresponds to those measured by biochemical techniques
in whole-liver extracts of S.mansoni-infected mice at 8 weeks after infection with 50 cercariae
(S.mansoni infected mice: 10.3 ±1.60 mg/g of wet liver, control mice: 0.591±1.144 mg/g of wet
Fig 4. Liver granulomatous pathology and fibrosis. (A) Intravascular adult parasite at 6 weeks post
infection (HE, scale bar 100 μm). (B) to (H): 10 weeks post infection. (B)Granuloma centred on one egg (HE,
scale bar 50 μm). (C) Focal hepatocellular necrosis (HE, scale bar 100 μm). (D) Periportal eosinophilic
inflammation (red arrow) around a bile duct (blue arrow) (HE, scale bar 100 μm). (E) and (F) Liver lobe
allowing assessment of the extent of granulomatous chronic inflammation and hepatitis (arrows pointing at
granulomas) in HE staining (E) and portal fibrosis with collagen deposition assessed with Sirius Red staining
(F) (bar 500 μm). Sirius Red facilitates quantification of extracellular matrix deposition of collagen within
granulomas (zoom in F, bar 100 μm). (G) and (H) Intergranulomatous fibrosis in HE staining (G) and Sirius
Red staining (H) (arrowhead pointing at granuloma and arrow at intergranulomatous fibrosis) (scale bar
500 μm). HE = Hematoxylin-Eosin.
doi:10.1371/journal.pntd.0004036.g004
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liver) [50]. However, deposition of collagen (Fig 4D) in the extracellular matrix in living tissue
is accompanied by pathophysiological reactions that have a measurable effect on relaxation
times [19]. We cannot discard the possibility that other components of the extra-cellular
matrix, which accumulate during fibrogenesis, (fibronectin, elastin, proteoglycan, hyaluronan
etc. . .) may contribute to T2 changes. Along the same line, it is not excluded that the observed
T2 increase in the liver of S.mansoni infected mice is due to the decreased content of hepatic
lipids [48], but further investigations are required.
In agreement with other in vivoMRI studies in animal models of hepatic fibrosis [35,36]
and in humans [51], at 10 weeks post infection we observed a T2 increase superior to 14% com-
pared to normal liver tissue. Although the T2 increase might be related to inflammation and
edema, the hepatic T2 values were not yet increased 6 weeks after infection (10.4 ± 2.4 versus
10.7 ± 2.5 ms in infected versus control mice) although histology revealed a discrete (A0 –A1)
portal inflammatory reaction at this stage of the disease, without any sign of fibrosis.
In contrast to previous works that assessed the alteration of the average T2 value in the pres-
ence of liver fibrosis [34,35,36,45], we quantified the area fraction of altered T2 on T2 maps of
liver tissue. This measure was not performed in previous studies, despite a non-uniform
Fig 5. Correlation between relaxometric and histological markers of disease severity.Disease severity as assessed by the METAVIR score (A) and
the area fraction stained with Sirius Red for collagen (B) increases mainly 6 weeks after infection. The area fraction of liver T2 values between 16 and 26 ms
obtained at 10 weeks after infection correlates with the METAVIR grading (C) and fibrosis quantification with Sirius Red staining (D). A 95% bivariate normal
density ellipse is represented on each scatterplot. (The correlations obtained for the values measured at 6 and 10 weeks are shown in S2A and S2B Fig).
doi:10.1371/journal.pntd.0004036.g005
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distribution of fibrosis in most cases and attempts to correlate quantitative MRI parameters to
the area fraction of fibrosis observed in histology. Our results demonstrate that despite the lack
of specificity of the T2 relaxation time, the area fraction of increased T2 in the liver is signifi-
cantly correlated with the area fraction affected by fibrosis. The area fraction of increased T2
enabled us to differentiate between early and intermediate fibrosis stages (i.e. stages F2).
Study limitations
This exploratory study on a small number of animals aimed at evaluating a non-invasive MRI
method for the assessment of liver fibrosis progression. A limitation of this study is that differ-
ent animal groups were used at the last two imaging time points, due to the fact that a valida-
tion by histology was mandatory. A longitudinal study on the same group of animals up to a
time point beyond 10 weeks post infection would be desirable.
Advantages
For disease monitoring and treatment evaluation in small animals T2 mapping is easy to imple-
ment and less challenging than transient elastography or MRE. Indeed, this technique does not
require the use of additional equipment such as vibrators and sequences for relaxometry are
readily available on standard pre-clinical MRI systems.
Magnetic resonance relaxometry has the advantage of being quantitative without any con-
trast agent injection that could interfere with biological parameters and alter disease develop-
ment. However, administration of a commercially available nonspecific extracellular contrast
agent such as Gd-DOTA enhanced the lesions, demonstrating increased vessel permeability.
The quantitative T2 and T2 maps performed in this study allow further optimization of
image weighting parameters for future studies on schistosomiasis.
Conclusion
T2 mapping is a quantitative and non-invasive marker of non-steatotic liver fibrosis with sensi-
tivity close to that of histology even at early stages.
This multiparametric and quantitative MRI approach can monitor hepatic and splenic dis-
ease progression and assess liver fibrosis non-invasively. In preclinical studies and in settings
were MRI facilities are readily available, this objective quantitative imaging biomarker may be
used to monitor response to therapy in diseases involving hepatic fibrosis.
Supporting Information
S1 Fig. Liver granulomatous pathology and fibrosis. A:Morphometrical analysis of fibrosis
(Sirius Red, scale bar 500 μm). B: Periovular granuloma with eosinophilic and lymphoplasmo-
cytic infiltration without collagen deposition 6 weeks post infection (HE, scale bar 50 μm). C:
Granuloma with multinucleate giant cells (arrows) containing brown pigment 10 weeks post
infection (HE, scale bar 50 μm).D:Negative Perls’ reaction confirms Hematin deposits within
a granuloma (Perls’ stain, scale bar 100 μm). HE = Hematoxylin-Eosin.
(TIF)
S2 Fig. Correlation between relaxometric and histological markers of disease severity for
values obtained at 6 weeks and 10 weeks after infection. The area fraction of liver T2 values
between 16 and 26 ms obtained at 6 and 10 weeks after infection correlates with the METAVIR
grading (A) and fibrosis quantification with Sirius Red staining (B). A 95% bivariate normal
density ellipse is represented on each scatterplot.
(TIF)
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